CN118403113A - Traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation - Google Patents
Traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation Download PDFInfo
- Publication number
- CN118403113A CN118403113A CN202410537998.2A CN202410537998A CN118403113A CN 118403113 A CN118403113 A CN 118403113A CN 202410537998 A CN202410537998 A CN 202410537998A CN 118403113 A CN118403113 A CN 118403113A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw
- traditional chinese
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 230000008961 swelling Effects 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 239000004863 Frankincense Substances 0.000 claims abstract description 23
- 235000012907 honey Nutrition 0.000 claims abstract description 22
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 20
- 241000489492 Arisaema Species 0.000 claims abstract description 18
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 17
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 17
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 17
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 17
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 17
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 16
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 16
- 229940010454 licorice Drugs 0.000 claims abstract description 16
- 241001116742 Drynaria Species 0.000 claims abstract description 13
- 241001254604 Angelica pubescens Species 0.000 claims abstract description 12
- 241000208682 Liquidambar Species 0.000 claims abstract description 12
- 235000006552 Liquidambar styraciflua Nutrition 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000002674 ointment Substances 0.000 claims abstract description 6
- 229940099259 vaseline Drugs 0.000 claims abstract description 5
- 238000000227 grinding Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 3
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 5
- 241001106477 Paeoniaceae Species 0.000 claims description 19
- 241000202807 Glycyrrhiza Species 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 10
- 238000001356 surgical procedure Methods 0.000 claims description 7
- 241000717739 Boswellia sacra Species 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 206010042674 Swelling Diseases 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 15
- 230000036592 analgesia Effects 0.000 abstract description 4
- 210000003462 vein Anatomy 0.000 abstract description 4
- 208000036487 Arthropathies Diseases 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 206010017076 Fracture Diseases 0.000 description 31
- 208000010392 Bone Fractures Diseases 0.000 description 29
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 241000219061 Rheum Species 0.000 description 12
- 210000003414 extremity Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 6
- 208000032912 Local swelling Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 241000227129 Aconitum Species 0.000 description 3
- 208000016285 Movement disease Diseases 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000001164 Osteoporotic Fractures Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 230000001926 lymphatic effect Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000002952 aconitine derivatives Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000000373 effect on fracture Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The application discloses a traditional Chinese medicine composition for treating swelling after fracture operation and joint movement limitation in the field of traditional Chinese medicines, which comprises the following components in parts by weight: 3-5 parts of raw radix aconiti, 3-5 parts of raw kusnezoff monkshood root, 3-5 parts of raw arisaema tuber, 5-10 parts of raw pollen typhae, 5-10 parts of frankincense, 5-10 parts of myrrh, 3-5 parts of safflower, 3-5 parts of red paeony root, 5-10 parts of raw rhubarb, 5-10 parts of beautiful sweetgum fruit, 5-10 parts of pubescent angelica root, 5-10 parts of drynaria rhizome, 1-3 parts of moxibustion licorice and 1-3 parts of honey. The traditional Chinese medicine composition has obvious effects of detumescence, analgesia, stasis removal and vein relaxing for swelling and joint dysfunction after fracture operation; grinding the above materials (except Mel) into superfine powder at a fixed ratio, heating vaseline, stirring, adding quantitative Mel, and making into ointment for topical application. The traditional Chinese medicine composition is suitable for patients with swelling and limited joint movement after fracture operation.
Description
Technical Field
The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation.
Background
With the high popularization of vehicles and the development of sports, the incidence of fracture is rising year by year, and in addition, with the aging of population, the incidence of osteoporosis and osteoporotic fracture is steadily rising in recent years. To promote healing of the fracture, reduce the occurrence of sequelae, fracture patients, particularly fractures of the joints of the extremities, often require surgical treatment. For displaced adult limb fractures with surgical indications, incision reduction internal fixation is the most common and preferred treatment for the surgeon. However, the fracture and the operation can generate trauma to the human body, and the vascular and lymphatic vessels are damaged, so that the vascular permeability is changed, the venous and lymphatic reflux is hindered, and simultaneously, the fracture is accompanied with inflammatory reaction which the fracture healing organism must experience, so that the patient still has local swelling after the fracture operation. And the local swelling soft tissue can press the blood vessels and nerves at the position, so that the blood circulation is blocked, the nerve feel and the dominant function are abnormal, skin infection or necrosis and deep vein thrombosis of lower limbs are caused when the blood circulation is severe, even bad results such as osteofascial chamber syndrome and the like occur, if the affected limb swelling and pain is improperly treated, pain of a patient can be aggravated, complications are induced, and fracture healing is affected. If the fracture accumulates on the joints of the limbs, swelling usually lasts for a long time after the fracture, and especially for the fracture postoperative recovery period patients with healed cuts, local soft tissue swelling and pain can further aggravate joint movement disorder, influence the later rehabilitation training of the patients, cause joint movement disorder which is difficult to recover, and bring heavy psychological burden and huge economic burden to the patients and family members. The main treatment modes of the modern medicine aiming at postoperative swelling at present comprise lifting affected limbs, cold therapy, pressurizing and binding, applying an arterial and venous pump device, medical treatment, applying a negative pressure lymphatic drainage system and the like; the treatment method for postoperative pain mainly comprises oral administration, intravenous injection and intramuscular injection of analgesic drugs. However, these treatments are only suitable for short term applications and remain to be improved in terms of reducing swelling after fracture surgery with little effect on the concomitant limitation of joint movement.
Swelling after fracture belongs to the category of fracture complicated with 'muscle injury' in traditional Chinese medicine, and the traditional Chinese medicine considers that fracture and operation can cause local injury of tendons and veins at affected parts to cause blood overflow outside the veins, blood is blood stasis after leaving channels, and the swelling is caused by 'blood tangible' and 'death of illness swelling'. The adverse blood is water, stagnant blood stagnates in the limbs, qi movement is not smooth, water channels are not smooth, and body fluid is not distributed, so that water dampness is caused to stop locally to form swelling. When the limbs are damaged, qi and blood are damaged, nutrient and defensive qi are not completely used, viscera are not completely used, and when various external factors damage the organism, internal dysfunction of viscera can be caused, physiological activities of normal qi and blood circulation in the organism are blocked, so that venation is not smooth, qi stagnates and blood stasis are caused, and local pain is caused. Impaired tendons and vessels, localized stagnant blood, obstruction of qi and blood, and unfavorable qi movement, which leads to joint movement disorder. Accordingly, the present invention aims to provide a Chinese medicinal composition for treating local swelling and pain after fracture and joint movement limitation, so as to solve the above problems.
Disclosure of Invention
The application aims to provide a traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation, which has obvious effects of detumescence and analgesia and removing blood stasis and dredging collaterals for joint dysfunction, and is suitable for patients with swelling and joint movement limitation after fracture operation.
In order to achieve the above object, the technical scheme of the present invention is as follows: a traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation comprises the following components in parts by weight: 3-5 parts of raw radix aconiti, 3-5 parts of raw kusnezoff monkshood root, 3-5 parts of raw arisaema tuber, 5-10 parts of raw pollen typhae, 5-10 parts of frankincense, 5-10 parts of myrrh, 3-5 parts of safflower, 3-5 parts of red paeony root, 5-10 parts of raw rhubarb, 5-10 parts of beautiful sweetgum fruit, 5-10 parts of pubescent angelica root, 5-10 parts of drynaria rhizome, 1-3 parts of moxibustion licorice and 1-3 parts of honey.
Further, the paint comprises the following components in parts by weight: 3 parts of raw radix aconiti, 3 parts of raw radix aconiti kusnezoffii, 3 parts of raw arisaema tuber, 5 parts of raw pollen typhae, 5 parts of frankincense, 5 parts of myrrh, 3 parts of safflower, 3 parts of red paeony root, 5 parts of raw rhubarb, 5 parts of fructus liquidambaris, 5 parts of radix angelicae pubescentis, 5 parts of rhizoma drynariae, 1 part of moxibustion licorice and 1 part of honey.
Further, the paint comprises the following components in parts by weight: 4 parts of raw radix aconiti, 4 parts of raw radix aconiti kusnezoffii, 4 parts of raw arisaema tuber, 8 parts of raw pollen typhae, 7 parts of frankincense, 8 parts of myrrh, 4 parts of safflower, 4 parts of red paeony root, 7 parts of raw rhubarb, 8 parts of beautiful sweetgum fruit, 7 parts of pubescent angelica root, 8 parts of drynaria rhizome, 2 parts of moxibustion licorice and 2 parts of honey.
Further, the paint comprises the following components in parts by weight: 5 parts of raw radix aconiti, 5 parts of raw radix aconiti kusnezoffii, 5 parts of raw arisaema tuber, 10 parts of raw pollen typhae, 10 parts of frankincense, 10 parts of myrrh, 5 parts of safflower, 5 parts of red paeony root, 10 parts of raw rhubarb, 10 parts of beautiful sweetgum fruit, 10 parts of pubescent angelica root, 10 parts of drynaria rhizome, 3 parts of moxibustion licorice and 3 parts of honey.
Further, the preparation method of the traditional Chinese medicine composition for treating swelling after fracture operation and joint movement limitation comprises the following steps:
Step one, raw material pretreatment: weighing radix et rhizoma Rhei, pollen Typhae, olibanum, myrrha, carthami flos, radix Paeoniae Rubra, radix Aconiti Kusnezoffii, rhizoma arisaematis, fructus Lipuidambaris, radix Angelicae Pubescentis, rhizoma Drynariae, and radix Glycyrrhizae Preparata at a certain ratio, and grinding into superfine powder;
Step two: preparation of the composition external ointment: heating vaseline, stirring the above superfine powder, adding Mel, making into ointment, and naturally cooling at normal temperature to obtain the final product.
The action mechanism of the medicine of the invention: the monarch drug raw kusnezoff monkshood root and raw common monkshood mother root are firstly carried in Shennong's herbal channel, are pungent and bitter in taste, have strong toxicity and have the effects of dispelling wind and removing dampness, warming channels and relieving pain, and the effects of dispelling wind and resolving masses and reinforcing detumescence by adding the raw arisaema tuber; the compatibility of the raw pollen typhae, the frankincense, the myrrh, the safflower and the red paeony root has the efficacy of activating blood and dissolving stasis; for blood stasis, qi stagnation is not caused, qi circulation is caused, so that it is advisable to add drugs for expelling wind-damp and dredging channels and collaterals, such as Lipuidambaris, radix Angelicae Pubescentis and rhizoma Drynariae, on the basis of the original prescription; the 'long-term stasis can remove heat' is assisted with the cold-nature blood-activating stasis-removing medicine raw rhubarb so as to warm and disperse cold Wen Deyi and cause heat diarrhea without causing heat accumulation or even toxicity; finally, the honey is matched with the honey and the honey to blend the medicines and reduce toxicity.
After the scheme is adopted, the following beneficial effects are realized:
(1) In the application, the mutual requirements of the raw radix aconiti and the raw radix aconiti are adopted, and the modern pharmacological research shows that a plurality of aconitine alkaloids in the radix aconiti and the radix aconiti have obvious central analgesic effect, and can paralyze peripheral nerve endings when being externally used, and the effects of detumescence and analgesia of the raw arisaema are doubled.
(2) According to the application, the olibanum and the red paeony root are cooperated, so that the effect of treating limb swelling can be achieved; the olibanum has the effects of promoting blood circulation, promoting qi circulation, relieving pain, detumescence and promoting granulation, and can promote venous return and relieve limb swelling; the red paeony root has the effects of clearing heat, cooling blood, removing stasis and relieving pain, and can play the roles of activating blood and dissolving stasis; the olibanum and the red paeony root are cooperated to help relieve the symptoms of joint swelling.
(3) The drynaria rhizome is added in the application, and is used for fracture injury, bone and muscle pain and other symptoms, and has good effect on fracture postoperative recovery; and honey are added, so that the honey and the honey can play a role in reducing toxicity, the traditional Chinese medicines of all the components achieve a synergistic effect, and the local allergy caused by external medicines is reduced.
(4) The traditional Chinese medicine composition has obvious effects of detumescence, analgesia, stasis removal and vein relaxing for postoperative local swelling and joint dysfunction; the ointment-shaped external preparation can exert the drug effect to the maximum extent on the lesion part, and can effectively avoid toxic and side effects caused by toxic drugs.
Detailed Description
The following is a further detailed description of the embodiments:
Example 1
A traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation comprises the following components in parts by weight: 3-5 parts of raw radix aconiti, 3-5 parts of raw kusnezoff monkshood root, 3-5 parts of raw arisaema tuber, 5-10 parts of raw pollen typhae, 5-10 parts of frankincense, 5-10 parts of myrrh, 3-5 parts of safflower, 3-5 parts of red paeony root, 5-10 parts of raw rhubarb, 5-10 parts of beautiful sweetgum fruit, 5-10 parts of pubescent angelica root, 5-10 parts of drynaria rhizome, 1-3 parts of moxibustion licorice and 1-3 parts of honey.
Example two
The difference between this embodiment and the above embodiment is that: comprises the following components in parts by weight: 3 parts of raw radix aconiti, 3 parts of raw radix aconiti kusnezoffii, 3 parts of raw arisaema tuber, 5 parts of raw pollen typhae, 5 parts of frankincense, 5 parts of myrrh, 3 parts of safflower, 3 parts of red paeony root, 5 parts of raw rhubarb, 5 parts of fructus liquidambaris, 5 parts of radix angelicae pubescentis, 5 parts of rhizoma drynariae, 1 part of moxibustion licorice and 1 part of honey.
Example III
The difference between this embodiment and the above embodiment is that: comprises the following components in parts by weight: 4 parts of raw radix aconiti, 4 parts of raw radix aconiti kusnezoffii, 4 parts of raw arisaema tuber, 8 parts of raw pollen typhae, 7 parts of frankincense, 8 parts of myrrh, 4 parts of safflower, 4 parts of red paeony root, 7 parts of raw rhubarb, 8 parts of beautiful sweetgum fruit, 7 parts of pubescent angelica root, 8 parts of drynaria rhizome, 2 parts of moxibustion licorice and 2 parts of honey.
Example IV
The difference between this embodiment and the above embodiment is that: comprises the following components in parts by weight: 5 parts of raw radix aconiti, 5 parts of raw radix aconiti kusnezoffii, 5 parts of raw arisaema tuber, 10 parts of raw pollen typhae, 10 parts of frankincense, 10 parts of myrrh, 5 parts of safflower, 5 parts of red paeony root, 10 parts of raw rhubarb, 10 parts of beautiful sweetgum fruit, 10 parts of pubescent angelica root, 10 parts of drynaria rhizome, 3 parts of moxibustion licorice and 3 parts of honey.
Example five
The difference between this embodiment and the above embodiment is that:
the preparation method of the traditional Chinese medicine composition for treating swelling after fracture operation and joint movement limitation comprises the following steps:
Step one, raw material pretreatment: weighing radix et rhizoma Rhei, pollen Typhae, olibanum, myrrha, carthami flos, radix Paeoniae Rubra, radix Aconiti Kusnezoffii, rhizoma arisaematis, fructus Lipuidambaris, radix Angelicae Pubescentis, rhizoma Drynariae, and radix Glycyrrhizae Preparata at a certain ratio, and grinding into superfine powder;
step two: preparation of composition external paste solution: heating vaseline, stirring the above superfine powder, adding Mel, making into ointment, and naturally cooling at normal temperature to obtain the final product.
Experiment verification
120 Patients with healed incision after limb fracture operation but limited local swelling and joint movement are selected as study subjects, and the patients are divided into a first experimental group (30), a second experimental group (30), a third experimental group (30) and a control group (30) by adopting a random number table method; subjects were between 18 and 70 years of age.
Experiment group one: the raw materials comprise the following components in parts by weight: 3 parts of raw radix aconiti, 3 parts of raw radix aconiti kusnezoffii, 3 parts of raw arisaema tuber, 5 parts of raw pollen typhae, 5 parts of frankincense, 5 parts of myrrh, 3 parts of safflower, 3 parts of red paeony root, 5 parts of raw rhubarb, 5 parts of fructus liquidambaris, 5 parts of radix angelicae pubescentis, 5 parts of rhizoma drynariae, 1 part of moxibustion licorice and 1 part of honey; the preparation method of the formula is prepared by referring to the fifth example.
Experimental group two: comprises the following components in parts by weight: 4 parts of raw radix aconiti, 4 parts of raw radix aconiti kusnezoffii, 4 parts of raw arisaema tuber, 8 parts of raw pollen typhae, 7 parts of frankincense, 8 parts of myrrh, 4 parts of safflower, 4 parts of red paeony root, 7 parts of raw rhubarb, 8 parts of beautiful sweetgum fruit, 7 parts of pubescent angelica root, 8 parts of drynaria rhizome, 2 parts of moxibustion licorice and 2 parts of honey; the preparation method of the formula is prepared by referring to the fifth example.
Experimental group three: comprises the following components in parts by weight: 5 parts of raw radix aconiti, 5 parts of raw radix aconiti kusnezoffii, 5 parts of raw arisaema tuber, 10 parts of raw pollen typhae, 10 parts of frankincense, 10 parts of myrrh, 5 parts of safflower, 5 parts of red paeony root, 10 parts of raw rhubarb, 10 parts of beautiful sweetgum fruit, 10 parts of pubescent angelica root, 10 parts of drynaria rhizome, 3 parts of moxibustion licorice and 3 parts of honey; the preparation method of the formula is prepared by referring to the fifth example.
Control group: comprises the following components in parts by weight: adding edible pigment into vaseline to obtain topical ointment with similar color.
The post-treatment efficacy versus treatment for the 4 groups of patients is shown in table 1:
TABLE 1
Group of | Number of examples | Healing | Has obvious effect | Effective and effective | Invalidation of |
Experiment group one | 30 | 15 | 10 | 5 | 0 |
Experiment group II | 30 | 11 | 10 | 9 | 0 |
Experiment group III | 30 | 8 | 12 | 10 | 0 |
Control group | 30 | 3 | 5 | 12 | 10 |
As can be seen from table 1, compared with the control group, the first experimental group, the second experimental group and the third experimental group prepared by referring to the composition of the application have more sufficient effects on treating swelling and limited joint movement after fracture operation, and the preparation method can more sufficiently excite the drug property, so that the treatment effect is sufficient; the nutritional composition provided by the application can relieve swelling and limited joint movement after fracture operation to a certain extent, and improve symptoms and signs of the fracture.
The foregoing is merely an embodiment of the present application, and a specific structure and characteristics of common knowledge in the art, which are well known in the scheme, are not described herein, so that a person of ordinary skill in the art knows all the prior art in the application date or before the priority date, can know all the prior art in the field, and has the capability of applying the conventional experimental means before the date, and a person of ordinary skill in the art can complete and implement the present embodiment in combination with his own capability in the light of the present application, and some typical known structures or known methods should not be an obstacle for a person of ordinary skill in the art to implement the present application. It should be noted that modifications and improvements can be made by those skilled in the art without departing from the structure of the present application, and these should also be considered as the scope of the present application, which does not affect the effect of the implementation of the present application and the utility of the patent. The protection scope of the present application is subject to the content of the claims, and the description of the specific embodiments and the like in the specification can be used for explaining the content of the claims.
Claims (5)
1. A traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation is characterized in that: comprises the following components in parts by weight: 3-5 parts of raw radix aconiti, 3-5 parts of raw kusnezoff monkshood root, 3-5 parts of raw arisaema tuber, 5-10 parts of raw pollen typhae, 5-10 parts of frankincense, 5-10 parts of myrrh, 3-5 parts of safflower, 3-5 parts of red paeony root, 5-10 parts of raw rhubarb, 5-10 parts of beautiful sweetgum fruit, 5-10 parts of pubescent angelica root, 5-10 parts of drynaria rhizome, 1-3 parts of moxibustion licorice and 1-3 parts of honey.
2. The traditional Chinese medicine composition for treating swelling and limited joint movement after fracture surgery according to claim 1, wherein the traditional Chinese medicine composition is characterized in that: comprises the following components in parts by weight: 3 parts of raw radix aconiti, 3 parts of raw radix aconiti kusnezoffii, 3 parts of raw arisaema tuber, 5 parts of raw pollen typhae, 5 parts of frankincense, 5 parts of myrrh, 3 parts of safflower, 3 parts of red paeony root, 5 parts of raw rhubarb, 5 parts of fructus liquidambaris, 5 parts of radix angelicae pubescentis, 5 parts of rhizoma drynariae, 1 part of moxibustion licorice and 1 part of honey.
3. The traditional Chinese medicine composition for treating swelling and limited joint movement after fracture surgery according to claim 2, wherein the traditional Chinese medicine composition is characterized in that: comprises the following components in parts by weight: 4 parts of raw radix aconiti, 4 parts of raw radix aconiti kusnezoffii, 4 parts of raw arisaema tuber, 8 parts of raw pollen typhae, 7 parts of frankincense, 8 parts of myrrh, 4 parts of safflower, 4 parts of red paeony root, 7 parts of raw rhubarb, 8 parts of beautiful sweetgum fruit, 7 parts of pubescent angelica root, 8 parts of drynaria rhizome, 2 parts of moxibustion licorice and 2 parts of honey.
4. The traditional Chinese medicine composition for treating swelling after fracture surgery and joint movement limitation according to claim 3, wherein: comprises the following components in parts by weight: 5 parts of raw radix aconiti, 5 parts of raw radix aconiti kusnezoffii, 5 parts of raw arisaema tuber, 10 parts of raw pollen typhae, 10 parts of frankincense, 10 parts of myrrh, 5 parts of safflower, 5 parts of red paeony root, 10 parts of raw rhubarb, 10 parts of beautiful sweetgum fruit, 10 parts of pubescent angelica root, 10 parts of drynaria rhizome, 3 parts of moxibustion licorice and 3 parts of honey.
5. The traditional Chinese medicine composition for treating swelling and limited joint movement after fracture surgery according to claim 4, wherein the traditional Chinese medicine composition is characterized in that: the method for preparing the traditional Chinese medicine composition for treating swelling after fracture surgery and joint movement limitation according to any one of claims 1 to 4, comprising the following steps:
Step one, raw material pretreatment: weighing radix et rhizoma Rhei, pollen Typhae, olibanum, myrrha, carthami flos, radix Paeoniae Rubra, radix Aconiti Kusnezoffii, rhizoma arisaematis, fructus Lipuidambaris, radix Angelicae Pubescentis, rhizoma Drynariae, and radix Glycyrrhizae Preparata at a certain ratio, and grinding into superfine powder;
Step two: preparation of the composition external ointment: heating vaseline, stirring the above superfine powder, adding Mel, making into ointment, and naturally cooling at normal temperature to obtain the final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410537998.2A CN118403113A (en) | 2024-04-30 | 2024-04-30 | Traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410537998.2A CN118403113A (en) | 2024-04-30 | 2024-04-30 | Traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118403113A true CN118403113A (en) | 2024-07-30 |
Family
ID=91982665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410537998.2A Pending CN118403113A (en) | 2024-04-30 | 2024-04-30 | Traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118403113A (en) |
-
2024
- 2024-04-30 CN CN202410537998.2A patent/CN118403113A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110327403A (en) | A kind of Chinese medicine fuming-lotion that treating rheumatic arthralgia and its application method | |
CN108175795A (en) | A kind of plaster | |
CN105056042A (en) | Medicinal liquor for treating traumatic injuries | |
CN112915173A (en) | Traditional Chinese medicine composition for treating orthopedic diseases, preparation method and application | |
CN104524174A (en) | Traditional Chinese medicine composition for treating rheumatic arthralgia and preparation method thereof | |
CN118403113A (en) | Traditional Chinese medicine composition for treating swelling and joint movement limitation after fracture operation | |
CN104147261B (en) | A kind of Chinese medicine preparation for treating rheumatic arthritis | |
CN1621050A (en) | Medicine for treating burns and scalds | |
CN105311210A (en) | Pharmaceutical composition for treating rheumatoid bone diseases | |
CN106421255B (en) | External Chinese herbal medicine composition and application thereof | |
CN116173160B (en) | External swelling-diminishing pain-relieving formula and application thereof | |
CN104491324A (en) | Aerosol for postoperative patient to promote blood circulation and remove obstruction in channels | |
CN104324097A (en) | Externally-applied traditional Chinese medicine composition for treating pain arthralgia type knee osteoarthritis | |
CN109620926B (en) | A traditional Chinese medicine external washing prescription for improving limb swelling, numbness and movement disorder after injured tendon fracture | |
CN116688042B (en) | Composition for promoting callus growth and relieving swelling and pain and preparation method thereof | |
CN108653588A (en) | External application traditional Chinese medicine for treating orthopedic diseases | |
CN102357130B (en) | Chinese herbal medicine composition for treating rheumatism | |
CN107115425A (en) | It is a kind of to be used to treat strong drug composition of traumatic injury and preparation method thereof | |
CN106421410A (en) | Traditional Chinese medicine composition for treating diabetic foot | |
CN107137591A (en) | A kind of Chinese medicine composition for treating atrophy disease | |
CN102784338B (en) | Traditional Chinese medicine fumigating and washing lotion for treating joint function disorder after fracturing | |
CN106581574A (en) | Exercise soft tissue injury treating traditional Chinese medicine and preparation method thereof | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
CN105194205A (en) | Chinese herbal medicine composition for treating fracture and joint soft tissue injury | |
CN105497817A (en) | Chinese herbal preparation for treating turgescence caused by trauma of ankle joint and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |